130 related articles for article (PubMed ID: 37660364)
1. Perfusion MRI in the evaluation of brain metastases: current practice review and rationale for study of baseline MR perfusion imaging prior to stereotactic radiosurgery (STARBEAM-X).
Dobeson CB; Birkbeck M; Bhatnagar P; Hall J; Pearson R; West S; English P; Butteriss D; Perthen J; Lewis J
Br J Radiol; 2023 Dec; 96(1152):20220462. PubMed ID: 37660364
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.
Cicone F; Minniti G; Romano A; Papa A; Scaringi C; Tavanti F; Bozzao A; Maurizi Enrici R; Scopinaro F
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):103-11. PubMed ID: 25182751
[TBL] [Abstract][Full Text] [Related]
3. Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgery.
Admojo L; Korte J; Anderson N; Phillips C; Caspersz L; Lasocki A
J Med Imaging Radiat Oncol; 2023 Apr; 67(3):292-298. PubMed ID: 36650724
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Response to Stereotactic Radiosurgery in Brain Metastases Using Multiparametric Magnetic Resonance Imaging and a Review of the Literature.
Sawlani V; Davies N; Patel M; Flintham R; Fong C; Heyes G; Cruickshank G; Steven N; Peet A; Hartley A; Benghiat H; Meade S; Sanghera P
Clin Oncol (R Coll Radiol); 2019 Jan; 31(1):41-49. PubMed ID: 30274767
[TBL] [Abstract][Full Text] [Related]
5. SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases.
Crouzen JA; Petoukhova AL; Broekman MLD; Fiocco M; Fisscher UJ; Franssen JH; Gadellaa-van Hooijdonk CGM; Kerkhof M; Kiderlen M; Mast ME; van Rij CM; Nandoe Tewarie R; van de Sande MAE; van der Toorn PPG; Vlasman R; Vos MJ; van der Voort van Zyp NCMG; Wiggenraad RGJ; Wiltink LM; Zindler JD
BMC Cancer; 2023 Mar; 23(1):273. PubMed ID: 36964529
[TBL] [Abstract][Full Text] [Related]
6. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
7. Temporal evolution of perfusion parameters in brain metastases treated with stereotactic radiosurgery: comparison of intravoxel incoherent motion and dynamic contrast enhanced MRI.
Kapadia A; Mehrabian H; Conklin J; Symons SP; Maralani PJ; Stanisz GJ; Sahgal A; Soliman H; Heyn CC
J Neurooncol; 2017 Oct; 135(1):119-127. PubMed ID: 28669014
[TBL] [Abstract][Full Text] [Related]
8. Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation.
Knitter JR; Erly WK; Stea BD; Lemole GM; Germano IM; Doshi AH; Nael K
AJR Am J Roentgenol; 2018 Jul; 211(1):168-175. PubMed ID: 29708785
[TBL] [Abstract][Full Text] [Related]
9. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
[TBL] [Abstract][Full Text] [Related]
10. DSC Perfusion MRI-Derived Fractional Tumor Burden and Relative CBV Differentiate Tumor Progression and Radiation Necrosis in Brain Metastases Treated with Stereotactic Radiosurgery.
Kuo F; Ng NN; Nagpal S; Pollom EL; Soltys S; Hayden-Gephart M; Li G; Born DE; Iv M
AJNR Am J Neuroradiol; 2022 May; 43(5):689-695. PubMed ID: 35483909
[TBL] [Abstract][Full Text] [Related]
11. [Monitoring of irradiated brain metastases using MR perfusion imaging and 1H MR spectroscopy].
Weber MA; Lichy MP; Thilmann C; Günther M; Bachert P; Maudsley AA; Delorme S; Schad LR; Debus J; Schlemmer HP
Radiologe; 2003 May; 43(5):388-95. PubMed ID: 12764588
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of Lesions after Stereotactic Radiosurgery for Brain Metastases: Impact of Delayed Contrast Magnetic Resonance Imaging.
Wagner S; Gufler H; Eichner G; Lanfermann H
Clin Oncol (R Coll Radiol); 2017 Mar; 29(3):143-150. PubMed ID: 27777145
[TBL] [Abstract][Full Text] [Related]
13. Diffusion and Perfusion MRI Predicts Response Preceding and Shortly After Radiosurgery to Brain Metastases: A Pilot Study.
Shah AD; Shridhar Konar A; Paudyal R; Oh JH; LoCastro E; Nuñez DA; Swinburne N; Vachha B; Ulaner GA; Young RJ; Holodny AI; Beal K; Shukla-Dave A; Hatzoglou V
J Neuroimaging; 2021 Mar; 31(2):317-323. PubMed ID: 33370467
[TBL] [Abstract][Full Text] [Related]
14. Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
Detsky JS; Keith J; Conklin J; Symons S; Myrehaug S; Sahgal A; Heyn CC; Soliman H
J Neurooncol; 2017 Sep; 134(2):433-441. PubMed ID: 28674974
[TBL] [Abstract][Full Text] [Related]
15. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery.
Mitsuya K; Nakasu Y; Horiguchi S; Harada H; Nishimura T; Bando E; Okawa H; Furukawa Y; Hirai T; Endo M
J Neurooncol; 2010 Aug; 99(1):81-8. PubMed ID: 20058049
[TBL] [Abstract][Full Text] [Related]
16. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
[TBL] [Abstract][Full Text] [Related]
17. Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy.
Kerkhof M; Ganeff I; Wiggenraad RGJ; Lycklama À Nijeholt GJ; Hammer S; Taphoorn MJB; Dirven L; Vos MJ
J Neurooncol; 2018 May; 138(1):133-139. PubMed ID: 29392588
[TBL] [Abstract][Full Text] [Related]
18. The Application of Magnetic Resonance Imaging-Deformed 11C-Methionine-Positron Emission Tomography Images in Stereotactic Radiosurgery.
Jung TY; Jung S; Ryu HS; Kim IY; Jang WY; Moon KS; Lim SH; Kim DY; Kang SR; Min JJ; Bom HS; Kim SK; Kwon SY
Stereotact Funct Neurosurg; 2019; 97(4):217-224. PubMed ID: 31694035
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging-based tumour perfusion parameters are biomarkers predicting response after radiation to brain metastases.
Jakubovic R; Sahgal A; Soliman H; Milwid R; Zhang L; Eilaghi A; Aviv RI
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):704-12. PubMed ID: 25023291
[TBL] [Abstract][Full Text] [Related]
20. Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastases.
Huber PE; Hawighorst H; Fuss M; van Kaick G; Wannenmacher MF; Debus J
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1339-49. PubMed ID: 11286842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
